Solentim (Group)

https://www.solentim.com

LinkedIn: https://www.linkedin.com/company/solentim

Solentim is the global leader in enabling accelerated cell line development for new biologic drugs through its proprietary intelligent automation. Solentim’s portfolio of products (VIPS™, Cell Metric® and Cell Metric® CLD) enables customers to establish a simple to use and completely integrated workflow, revolutionising single cell cloning and providing documented daily whole well image assurance of monoclonality for FDA and other regulatory bodies. Solentim works with the world’s top 10 pharmaceutical companies and has a customer installed base of several hundred instruments. It also has established strategic partnerships with ATUM and Valitacell. In 2018, Solentim was the recipient of two highly prestigious Queen’s Awards for Enterprise and was also named in the Deloitte UK Technology Fast 50. *

	Start	2010-01-01 established
	Industry	Cell Metric™ system
	Industry 2	VIPS™ (verified in-situ plate seeding) system
	Person	Truesdale, Mark (Solentim 202003– CEO joined 201910– as Chief Marketing Officer before Thermo Fisher + Genetix)
	Person 2	Figg, Aaron (Solentim 201910 Managing Director)

	Street	Johnson Road, Solent House Fernside Business Park
	City	BH21 7SE Wimborne, Dorset
	Tel	+44-1202-798510
		Address record changed: 2024-01-05

Basic data	Employees	B: 11 to 50 (2019-01-14)

		* Document for »About Section«: Solentim Ltd.. (10/1/19). "Press Release: Dr Mark Truesdale Joins Solentim as New Chief Marketing Officer". Bournemouth.

		Record changed: 2023-07-10